Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03493555 · ClinicalTrials.gov registry record · NA
Optimizing PrEP Adherence for Young Men Who Have Sex With Men
A NA study of Pre-exposure Prophylaxis, sponsored by Fenway Community Health.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03493555: Completed NA study of Pre-exposure Prophylaxis, sponsored by Fenway Community Health.
NCT03493555 is a NA study of Pre-exposure Prophylaxis that has completed, run by Fenway Community Health. The registered enrollment target is 50 participants, below the 189-participant average among 12 other Pre-exposure Prophylaxis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03493555, a NA study of Pre-exposure Prophylaxis, has completed, sponsored by Fenway Community Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aims of this study are: 1. To explore perceived facilitators and barriers to initiating and adhering to HIV PRE-EXPOSURE PROPHYLAXIS (PrEP) among at-risk YOUNG MEN WHO HAVE SEX WITH MEN (YMSM). 2. To assess the acceptability and feasibility of a culturally-tailored peer navigator program to optimize adherence to PrEP among YMSM.
Primary Outcome
For the primary outcome, the investigators will conduct qualitative interviews (using an IRB-approved semi-structured interview guide) at 3 and 6 months post-enrollment. Additionally, a question about acceptability of the intervention will be asked at 3 and 6 months post-enrollment. An affirmative response rate of 70% or higher will indicate acceptability of the intervention.
Conditions Studied
Interventions
- BEHAVIORAL Peer Health Navigator for PrEP
Study Locations (1)
Massachusetts
- The Fenway Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-05-04 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT03493555 record still lists
NCT03493555 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 189-participant average among 12 other Pre-exposure Prophylaxis trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Pre-exposure Prophylaxis appearing as the primary indexed condition, and to 1 intervention - of which Peer Health Navigator for PrEP is the first listed.
NCT03493555 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03493555 about?
NCT03493555 is a clinical study titled "Optimizing PrEP Adherence for Young Men Who Have Sex With Men". The specific aims of this study are: 1. To explore perceived facilitators and barriers to initiating and adhering to HIV PRE-EXPOSURE PROPHYLAXIS (PrEP) among at-risk YOUNG MEN WHO HAVE SEX WITH MEN (YMSM). 2. To assess the acceptability and feasibility of a culturally-tailored peer navigator progr...
What is the current status of trial NCT03493555?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-05-04. Estimated completion is 2018-09-30.
What conditions does trial NCT03493555 study?
This clinical trial studies the following conditions: Pre-exposure Prophylaxis.
What interventions are being tested in trial NCT03493555?
The interventions under investigation include: Peer Health Navigator for PrEP (BEHAVIORAL).
Who is sponsoring clinical trial NCT03493555?
This trial is sponsored by Fenway Community Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03493555 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre-exposure Prophylaxis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03493555's enrollment target sits among peer trials
50 10th of 12 higher than 3 of 12 other Pre-exposure Prophylaxis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pre-exposure Prophylaxis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
-
Stick2PrEP Cisgender Women and Trans Individuals
RECRUITING · NA
-
Gathering Online for Dialogue and Discussion to Enhance Social Support
RECRUITING · NA
-
Case Management Dyad
RECRUITING · NA
-
Information Seeking About Pre-exposure Prophylaxis
COMPLETED · NA
-
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI